Pulmonary lesions associated with busulfan therapy of chronic myelogenous leukemia.
D000328:Adult; D000368:Aged; D001982:Bronchial Diseases / Q000139:chemically induced; D002066:Busulfan / Q000009:adverse effects* / Q000494:pharmacology; D004848:Epithelium / Q000473:pathology; D005260:Female; D006801:Humans; D006965:Hyperplasia / Q000139:chemically induced; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D008168:Lung / Q000187:drug effects; D008171:Lung Diseases / Q000139:chemically induced* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D010179:Pancreas / Q000187:drug effects / Q000473:pathology; D011650:Pulmonary Alveoli / Q000473:pathology; D011654:Pulmonary Edema / Q000139:chemically induced; D011658:Pulmonary Fibrosis / Q000139:chemically induced
D002066:Busulfan